Feline leukemia viruses (FeLVs) are a group of horizontally transmitted type C retroviruses capable of induction of neoplastic and degenerative diseases of the feline lymphoreticular system (16, 28, 31, 44) . The FeLV family consists of three known subgroups, FeLV-A, FeLV-B, and FeLV-C, defined by virus interference and neutralization (60) . Distribution of the different subgroups within feline populations differs markedly. All field isolates of FeLV contain FeLV-A either alone or in a mixture of subgroups (60) , whereas FeLV-C has been isolated rarely in nature, and only in animals with severe degenerative disease (23, 31, 48, 60) .
Feline aplastic anemia (AA) is a naturally occurring disease known for over a decade to be caused by infection with certain isolates of FeLV (26, 37) . Feline AA is characterized by erythroid aplasia manifested as severe nonregenerative anemia, by lymphopenia, and in later stages by granulocytopenia, leukopenia, and myelosclerosis (26, 29) . Only a few naturally occurring isolates of FeLV, all of which belong to the C subgroup, are known to be capable of consistent induction of AA (26, 48) . The anemogenic capacity of FeLV isolates, therefore, is considered to be specific for subgroup C viruses (30, 48) . The pathology of feline AA is directly analogous to that of human AA (12, 32) . Since no other virus is known to induce this type of anemia (30, 48) , FeLV 13 -kilobase EcoRI fragment. The env-LTR region was subcloned as a 2.9-kilobase XhoI-BamHI fragment into the SaIl-BamHI sites of M13mpl8 (pFSC-ENV-LTR). P, PstI; H2, HincII; K, KpnI; H3, HindlIl; B, BamHI; X, XhoI; B2, BglII; RI, EcoRI. (30) . The molecular mechanism for the induction of irreversible erythroid aplasia leading to fatal AA, therefore, lies in the molecular analysis of the FeLV-C genome.
Here we describe the molecular cloning of an FeLV-C provirus, demonstrate that it encodes a potent anemogenic virus of predictable, acute pathology, present the nucleotide sequences of its envelope gene and LTR, and compare them with the envelope gene and LTR sequences of FeLV-B-GA, a potent inducer of a distinctly different disease.
MATERIALS AND METHODS Molecular cloning, transfection, and DNA sequence analysis. The source of FeLV-C virus for these experiments was the biologically cloned isolate of Sarma, FeLV-C-S (60) , introduced by infection into human rhabdomyosarcoma cells (38) . DNA from rhabdomyosarcoma cells infected with FeLV-C-S was digested with EcoRI, an enzyme which does not cleave the FeLV-C-S genome (data not shown), and fractionated on a sucrose gradient (43) . Fractions contaihing 8-to 25 -kilobase (kb) DNA were identified by gel electrophoresis and subsequently ligated into the bacteriophage vector Charon 4A (43) . The resulting phage library was screened with 32P-nick-translated pFGB, a probe containing an entire FeLV-B-GA provirus (15) . Several clones containing two LTRs were identified by hybridization with a probe specific for exogenous LTR sequences (7) and used to transfect AH927 feline (W. Nelson-Rees), D-17c-1 canine (J. Riggs), rhabdomyosarcoma human (38) , and GP104 guinea pig fibroblasts (ATCC 158). Cells were tested for production of reverse transcriptase 4 weeks after transfection (45) .
The restriction map of a representative, reverse-transcriptase-positive, and biologically active (see Fig. 1 ) clone (XFSC5) was determined after subcloning of the entire EcoRI fragment into the plasmid vector pK125 (D. Goldberg, personal communication). A XhoI-BamHI fragment containing the entire envelope and LTR was subcloned into the SalI-BamHI sites of M13mpl8 (46) . Deletion clones were then derived by using the double-strand exonuclease BAL 31 (51) and were sequenced by using the dideoxynucleotide chain termination method (59) .
Virus interference test. Subgroup determination with virus derived from feline fibroblasts transfected with plasmid clone pFSC was performed by 0. Jarrett according to protocols described previously (30, 31, 57 (30, 31, 57 [18] ) of FeLV-C-S prepared as cell culture fluid from productively transfected D17-cl cells. One kitten from each litter served as an uninoculated control. At biweekly intervals postinoculation, blood and bone marrow were collected from each cat and methanol-fixed films were prepared for the detection of FeLV viral structural antigen p27 in leukocytes, platelets, and marrow cells by immunofluorescence by using a procedure modified (27) capable of growth in all cell lines tested, whereas molecularclone-derived FeLV-B-GA did not grow in guinea pig cells (data not shown). These results are consistent with previous studies using biologically cloned virus (58) . Interference studies conducted with virus derived from transfected feline fibroblasts demonstrated that clone pFSC encodes a subgroup C FeLV (data not shown).
In vivo pathogenesis of FeLV-C-S. Cell-free supernatants of canine cells productively transfected with FeLV-C-S were injected into neonatal (<3-day-old) or 8-week-old cats. None of the 8-week-old animals developed viremia, whereas nine of ten neonatal cats developed persistent viremia by 3 weeks postinoculation and rapidly progressive nonregenerative anemia, which was terminal between 3 and 8 weeks postinoculation (Table 1 ). In marrow clonogenic assays, these cats demonstrated a precipitous decline in erythroid progenitor colony-forming cells (burst-forming units, erythroid, BFU-e) after the onset of viremia and before the onset of anemia, which persisted throughout the disease course. Anemia was defined as a decline in the hematocrit. For one litter, serial assays of bone marrow BFU-e and CFU (erythroid and 40- ii e0 -granulocyte-macrophage) progenitor cells were performed ( Fig. 2) . Marked decreases in BFU-e and erythroid CFU were evident in each inoculated animal relative to an uninoculated littermate control (Fig. 2) . A parallel decrease in marrow erythroid progenitor cells was evident in stained films and in counts of total marrow nucleated cells (not shown). In contrast, no significant decrease in granulocytemacrophage CFU was apparent at these same intervals ( These results demonstrate that molecularly cloned FeLV-C-S is a potent, reproducible inducer of erythroid-cellspecific pathogenesis comparable in potency to biologically passaged isolates of FeLV-C (5, 19, 26, 30, 48, 64) .
In contrast, inoculation of neonatal cats with molecularclone-derived FeLV-B-GA virus specifically and reproduc- The gp7O molecules of FeLV-B-GA and FeLV-C-S share eight potential glycosylation signals (Asn-X-Thr/Ser) (41) (Fig. 4A, overlined) . However, three additional glycosylation sites were found in FeLV-B-GA, each within a block of evident sequence substitution (Fig. 4A, double underlined) .
As mentioned previously, the gp7O of FeLV-B-GA was shown to share three regions of significant homology with murine MCF viruses, regions which are not shared with murine ecotropic virus gp70s (15) . Three of these four regions (Fig. 4A, underlined) (21) and Goldberg-Hogness (TATAAAA) (11, 17, 53) boxes, the presumed polyadenylation recognition signal (AATAAA) (54) , and the polyadenylation addition site (CA) (54) regions of high homology between FeLV-B-GA and murine MCF virus gp7O, as described earlier (15 (17) . These include the CCAAT box (21) and the Goldberg-Hogness box (11, 17, 53) in the U3 region of the LTR, which play roles in the promotion of transcription. The U3 regions also contain enhancerlike sequences (36) , and the FeSV-B-GA LTR was previously shown to have promoter and enhancer activity (9) . Several regions of the FeLV-B-GA and FeLV-C-S LTR show strong homology to a 72-base-pair repeat in MSV, the latter of which was shown to enhance transcription of papovavirus early genes when substituted for the 72-basepair repeat of simian virus 40 (34) .
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An LTR sequence comparison between FeLV-C-S and FeLV-B-GA is shown in Fig. 3B . The 12-base inverted repeats found at the ends of the LTRs are identical, whereas the inverted repeat of FeLV-C-S is immediately followed by five cytosine residues not found in FeLV-B-GA. The FeLV-C-S LTR encompasses the following 489 nucleotides (482 for FeLV-B-GA): 346 nucleotides in U3 (340 for FeLV-B-GA, over which the homology is 92.5%); 68 nucleotides in the R region (67 for FeLV-B-GA, with no base substitutions); and 75 nucleotides in both U5 regions, in which there is 98.7% homology. A palindromic sequence within the R region (Fig.  3B, underlined) was proposed to function as a termination sequence of transcription due to the formation of a hairpinlike structure (2, 15, 25) ; 35 of 36 bases in this region are conserved between the two LTRs. DISCUSSION We described molecular cloning of FeLV-C-S and demonstrated that it alone is sufficient to induce rapid, fatal AA in neonatal kittens associated with ablation of bone marrow BFU-e. Since subgroup C FeLVs are the only known inducers of nonregenerative AA, studies with this prototype virus should permit us to examine mechanisms and pathways of stem cell suppression. The relevance of retroviruses as agents of aplasia is amplified by the increasing body of evidence indicating that naturally occurring human retroviruses are responsible for both cytosuppressive and cytoproliferative hemolymphatic human diseases (35, 40, 52, 65 (30) , or to the fact that many more cells in the cat may be susceptible to FeLV-A compared with FeLV-B and FeLV-C, thus allowing rapid spread and growth of subgroups B and C in weanling and adult cats by phenotypic mixing (30) . The gp70 protein might therefore play an important role in target-cell specificity for pathogenesis. However, growth of FeLV-C-S in kittens is not restricted to cells of the hemopoietic system (26) , indicating that additional factors, coded for by the FeLV-C genome, may play a crucial role in the rapid depletion of early erythroid progenitor cells.
Comparison of the piSE proteins and LTRs of FeLV subgroups B and C revealed a high degree of homology. The few changes in the putative enhancerlike regions of the FeLV-B-GA ahd FeLV-C-S LTRs are mostly transition mutations, which may not be sufficient to account for the described differences in pathogenesis, but the importance of single nucleotide changes to the function of this region has not been adequately explored. The five cytosines positioned immediately downstream of the inverted repeat at the 5' end of the FeLV-C-S U3 region are not unique to this strain of FeLV; four cytosines are present in the same position of the FeLV-B-Snyder-Theilen LTR (22) . Previous studies of murine viruses reported that substitution of the LTR of a leukemogenic virus (SL3-3) into a nonleukemogenic virus (Akv) results in the formation of a potent leukemogenic virus in mice (8) . However, the role of other regions of the viral genome during induction of leukemia by SL3-3 viruses was not examined, and recent data (C. Y. Thomas, personal communication) show that induction of leukemia by the SL3-3 virus is associated with the formation of envelope gene recombinant murine leukemia viruses. Additional regulatory processes on the level of provirus integration, the requirement of a certain cellular environment for activity, and possibly provirus-encoded transacting transcription activators (6, 62) could contribute to host range, tissue tropism, and viral pathogenesis. We are therefore constructing recombinant viruses between a minimally pathogenic FeLV-A (J. Overbaugh, E. A. Hoover, and J. I. Mullins, unpublished data) and FeLV-C-S to investigate the role of individual viral genes in pathogenic specificity.
